Q4 2025 Holdings
Filed 2026-02-17 | 23 holdings | $404.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $37.9M | 1,419,406 | 9.4% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $34.4M | 2,568,110 | 8.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $34.0M | 737,470 | 8.4% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $33.1M | 1,743,220 | 8.2% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $31.1M | 1,395,608 | 7.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $26.8M | 597,092 | 6.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $23.7M | 682,597 | 5.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $21.8M | 916,313 | 5.4% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $18.4M | 700,000 | 4.5% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $16.2M | 785,000 | 4.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $14.9M | 1,043,313 | 3.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $14.5M | 192,000 | 3.6% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $12.7M | 6,178,124 | 3.1% |
| Inventiva SA(IVA) | ADS | 46124U107 | $12.4M | 2,657,997 | 3.1% |
| Camp4 Therapeutics Corp(CAMP) | COM | 13463J101 | $12.2M | 1,983,986 | 3.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $12.1M | 300,000 | 3.0% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $10.3M | 2,571,478 | 2.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $9.9M | 315,158 | 2.5% |
| VTV Therapeutics Inc(VTVT) | CL A NEW | 918385204 | $9.2M | 231,000 | 2.3% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $7.6M | 1,415,273 | 1.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $6.1M | 240,165 | 1.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $3.1M | 199,306 | 0.8% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.5M | 31,862 | 0.6% |